Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIMK1 | P53667 | 8/20 | 0.55 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.55 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.55 |
| ▸ | TNKS | O95271 | 1/20 | 0.50 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.50 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.48 |
| ▸ | EGFR | P00533 | 4/20 | 0.47 |
| ▸ | HTR2C | P28335 | 1/20 | 0.45 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.44 |
| ▸ | CLK1 | P49759 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16901973 | 0.88 | LIMK1 (0.61) | LIMK1CDK5CDK5R1HRH4EGFR | |
| SCHEMBL20809400 | 0.87 | LIMK1 (0.54) | LIMK1CDK5CDK5R1TNKSTNKS2 | |
| SCHEMBL16910634 | 0.85 | LIMK1 (0.55) | LIMK1CDK5CDK5R1HRH4EGFR | |
| SCHEMBL17754619 | 0.85 | LIMK1 (0.51) | LIMK1CDK5CDK5R1HRH4EGFR | |
| SCHEMBL23185176 | 0.80 | LIMK1 (0.52) | LIMK1CDK5CDK5R1HRH4EGFR | |
| SCHEMBL26351566 | 0.79 | LIMK1 (0.55) | LIMK1CDK5CDK5R1HRH4EGFR | |
| SCHEMBL24796187 | 0.79 | LIMK1 (0.46) | LIMK1CDK5CDK5R1TNKSTNKS2 | |
| SCHEMBL16922360 | 0.79 | LIMK1 (0.51) | LIMK1CDK5CDK5R1HRH4EGFR | |
| SCHEMBL17427849 | 0.79 | LIMK1 (0.57) | LIMK1CDK5CDK5R1HRH4EGFR | |
| SCHEMBL18269973 | 0.79 | LIMK1 (0.57) | LIMK1CDK5CDK5R1HRH4EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9761814-B2 | Organic light-emitting materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2017-09-12 | — | — | US | disclosed |
| US-9761814-B2 | Organic light-emitting materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2017-09-12 | — | — | US | disclosed |
| US-20160141525-A1 | ORGANIC LIGHT-EMITTING MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-05-19 | — | — | US | disclosed |
| US-20160141525-A1 | ORGANIC LIGHT-EMITTING MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160141525-A1 | ORGANIC LIGHT-EMITTING MATERIALS AND DEVICES | OCIAD1, OCIAD2, OSBPL3 | LIMK1 1441/4885CDK5 1187/4885CDK5R1 2622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.